Warning: The NCBI web site requires JavaScript to function. more...
Mammary carcinoma behavior is programmed in the precancer stem cell.
Damonte P, Hodgson JG, Chen JQ, Young LJ, Cardiff RD, Borowsky AD.
Breast Cancer Res. 2008;10(3):R50. Epub 2008 Jun 3.
Related citations
Heterogeneity of mammary lesions represent molecular differences.
Namba R, Maglione JE, Davis RR, Baron CA, Liu S, Carmack CE, Young LJ, Borowsky AD, Cardiff RD, Gregg JP.
BMC Cancer. 2006 Dec 5;6:275.
Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes.
Maglione JE, McGoldrick ET, Young LJ, Namba R, Gregg JP, Liu L, Moghanaki D, Ellies LG, Borowsky AD, Cardiff RD, MacLeod CL.
Mol Cancer Ther. 2004 Aug;3(8):941-53.
Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q, Zhang QB, Dong J, Wu YY, Shen YT, Zhao YD, Zhu YD, Diao Y, Wang AD, Lan Q.
BMC Cancer. 2008 Oct 22;8:304.
p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro.
Ozbun MA, Jerry DJ, Kittrell FS, Medina D, Butel JS.
Cancer Res. 1993 Apr 1;53(7):1646-52.
Immortalization phenotype dissociated from the preneoplastic phenotype in mouse mammary epithelial outgrowths in vivo.
Medina D, Kittrell FS.
Carcinogenesis. 1993 Jan;14(1):25-8.
Biological and genetic properties of the p53 null preneoplastic mammary epithelium.
Medina D, Kittrell FS, Shepard A, Stephens LC, Jiang C, Lu J, Allred DC, McCarthy M, Ullrich RL.
FASEB J. 2002 Jun;16(8):881-3. Epub 2002 Apr 10.
Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin.
Hellmén E, Moller M, Blankenstein MA, Andersson L, Westermark B.
Breast Cancer Res Treat. 2000 Jun;61(3):197-210.
Malignant myoepithelial cells are associated with the differentiated papillary structure and metastatic ability of a syngeneic murine mammary adenocarcinoma model.
Bumaschny V, Urtreger A, Diament M, Krasnapolski M, Fiszman G, Klein S, Joffé EB.
Breast Cancer Res. 2004;6(2):R116-29. Epub 2004 Jan 15.
The properties of a mammary gland cancer stem cell.
Zucchi I, Sanzone S, Astigiano S, Pelucchi P, Scotti M, Valsecchi V, Barbieri O, Bertoli G, Albertini A, Reinbold RA, Dulbecco R.
Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10476-81. Epub 2007 Jun 12.
Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ.
Namba R, Maglione JE, Young LJ, Borowsky AD, Cardiff RD, MacLeod CL, Gregg JP.
Mol Cancer Res. 2004 Aug;2(8):453-63.
Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition.
McCoy EL, Iwanaga R, Jedlicka P, Abbey NS, Chodosh LA, Heichman KA, Welm AL, Ford HL.
J Clin Invest. 2009 Sep;119(9):2663-77. doi: 10.1172/JCI37691. Epub 2009 Aug 24.
Expression of gicerin enhances the invasive and metastatic activities of a mouse mammary carcinoma cell line.
Tsukamoto Y, Sakaiuchi T, Hiroi S, Furuya M, Tsuchiya S, Sasaki F, Miki N, Taira E.
Int J Oncol. 2003 Dec;23(6):1671-7.
Human mammary cancer progression model recapitulates methylation events associated with breast premalignancy.
Dumont N, Crawford YG, Sigaroudinia M, Nagrani SS, Wilson MB, Buehring GC, Turashvili G, Aparicio S, Gauthier ML, Fordyce CA, McDermott KM, Tlsty TD.
Breast Cancer Res. 2009;11(6):R87. Epub 2009 Dec 8.
Morphological and functional properties of TM preneoplastic mammary outgrowths.
Medina D, Kittrell FS, Liu YJ, Schwartz M.
Cancer Res. 1993 Feb 1;53(3):663-7.
Collagen density promotes mammary tumor initiation and progression.
Provenzano PP, Inman DR, Eliceiri KW, Knittel JG, Yan L, Rueden CT, White JG, Keely PJ.
BMC Med. 2008 Apr 28;6:11.
Enhancement of the tumorigenicity of preneoplastic mammary nodule lines by enzymatic dissociation.
Medina D, Shepherd F, Gropp T.
J Natl Cancer Inst. 1978 May;60(5):1121-6.
Establishment of two hormone-responsive mouse mammary carcinoma cell lines derived from a metastatic mammary tumor.
Efeyan A, Fabris V, Merani S, Lanari C, Molinolo AA.
Breast Cancer Res Treat. 2004 Feb;83(3):233-44.
Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1.
Wright MH, Robles AI, Herschkowitz JI, Hollingshead MG, Anver MR, Perou CM, Varticovski L.
Mol Cancer. 2008 Apr 7;7:29.
Two-dimensional gel analysis of polypeptides from normal, preneoplastic and neoplastic mouse mammary tissues.
Maloney T, Wei WZ.
Cancer Immunol Immunother. 1990;30(6):367-73.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on